Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2018-12-06
Target enrollment:
Participant gender:
Summary
A Phase 2 study Comparing the effects on glucose control of MEDI0382 in combination with
Dapagliflozin and Metformin compared to placebo in combination with Dapagliflozin and
Metformin in overweight/obese participants with Type 2 Diabetes Mellitus (T2DM).